Svetlana V. Doubova Dolores Mino-Leon Hortensia Reyes Morales Sergio Flores-Hernández Ricardo Pérez-Cuevas.

Slides:



Advertisements
Similar presentations
THE INAPPROPRIATE SALE OF MEDICATION FOR PEDIATRIC USE IN SIEM REAP PROVINCE, KINGDOM OF CAMBODIA AUTHORS: Sothearith Tiv Ph., Rathi Guhadasan MBBS MRCP.
Advertisements

ROAD SAFETY ETP EVALUATION TRAINING
AN EVALUATION OF A CLINICAL PHARMACIST DIRECTED-INTERVENTION
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 04- The Nursing Process.
Drug Utilization Review (DUR)
Guidelines for Pain Management Paula Wilkinson Chief Pharmacist NHS Mid-Essex.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2009.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December 2007.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2011.
Contributions to research Theresa Byrd, Dr.PH Associate Dean and Chair Department of Public Health TTUHSC.
Readmission and Chronic illness that could benefit from end of life discussions.
Clinical pharmacy Dr. Mohammed Al-Rekabi Lecture One First Semester.
Implementation of local guideline by interactive workshop improves anticoagulation therapy and patient safety Puhakka J, Helsinki Health Centre, GP Suvanto.
Impact of a public education program on promoting rational use of medicines: a household survey in south district of Tehran, Darbooy SH, Hosseini.
Evaluating the quality of care for patients with type 2 diabetes using the electronic medical record information in Mexico 1 Epidemiology and Health Services.
IMPACT OF EDUCATIONAL INTERVENTION ON PRESCRIBING BEHAVIOUR AND COST OF THERAPY IN BRONCHIAL ASTHMA IN COLONY HOSPITALS OF DELHI Kotwani A, Gupta U, Suri.
Committee Questions Design, Statistical Considerations and Study Conduct 1. There are no clear guidelines regarding the number of people that should be.
Responsibilities and Principles of Drug Administration
Extending nursing roles through protocols and standing orders workshop Gpnz/rnzcgp conference Auckland 4/9/2011 D –
Evaluation of a Pharmacist-conducted Medication Reconciliation Program upon Admission in a Medical Center in Taiwan Yen-Ying Lee, M.S., PharmD 1,2, Tzu-Ying.
Summary of ICIUM Chronic Care Track Prepared by: Ricardo Perez-Cuevas Veronika Wirtz David Beran.
EFFECTIVENESS OF A MEDICAL EDUCATION INTERVENTION TO TREAT HYPERTENSION IN PRIMARY CARE Authors Institutions Authors: Silvia Martínez-Valverde MSc 1, Hortensia.
Meta-Analysis of HIV Risk Reduction Interventions Within Drug Abuse Treatment Programs By: Dana Trent June 2001
Texas State Board of Medical Examiners Bruce A. Levy, M.D., J.D.
Materials and methods. RESULTS INTRODUCTION Conclusion Knowledge, expectations and self medication in the adult population in the Republic of Macedonia.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2012.
VACCINE STORAGE AND ADMINISTRATION AMONG PRIMARY HEALTH CARE WORKERS IN SOUTH-EAST NIGERIA: EFFECT OF EDUCATIONAL INTERVENTION UZOCHUKWU BSC, ONWUJEKWE.
Determinants of Rational Use of Medicines Dr A K Sharma Prof & Head Dept of Pharmacology AFMC, Pune.
Adverse Outcomes After Hospitalization and Delirium in Persons with Alzheimer Disease Charles Wang, PharmD Candidate.
Focus Area 17: Medical Product Safety Progress Review November 5, 2003.
An Intervention To Improve Antibiotic Prescribing Habits of Doctors in a Teaching Hospital Ofei F, Forson A, Tetteh R, Ofori-Adjei D University of Ghana.
Medication Practices for the Elderly in U.S. Nursing Homes Lisa L. Dwyer, MPH Robin E. Remsburg, PhD, APRN, BC Division of Health Care Statistics National.
1 Impact of Implementing Designed Nursing Intervention Protocol on Clinical Outcome of Patient with Peptic Ulcer By Amal Mohamed Ahmad Assistant Professor,
Summary Pattern of Specific COX II Inhibitors Use Physician prescribed appropriate COX II use in high risk was 40.08% and inappropriate COX II use in low.
Optimization of psychotropic drug prescription in nursing home patients with dementia: the PROPER study (PRescription Optimization of Psychotropic drugs.
Claire Oates Renal pharmacist North Bristol NHS Trust
Empowering residents to address chronic pain and prescription opioid misuse in primary care A.L. Ruff, M.D. 1, D. P. Alford, M.D, M.P.H. 2, R. Butler 3,
INTRODUCTION Faridah Baroroh Faculty of Pharmacy, Ahmad Dahlan University Yogyakarta, Indonesia ABSTRACT Conclusion RESEARCH METHOD This.
A Multifaceted Continuing Medical Education Intervention to Improve Primary Care Physicians’ Performance In Mexico Hortensia Reyes, Ricardo Perez-Cuevas,
Medicines Optimisation Polypharmacy and Deprescribing
Risk Management of Modified- Release Opiate Analgesics: Palladone Sharon Hertz, M.D. Medical Team Leader, Analgesics Division of Anesthetic, Critical Care,
Mexican Institute of Social Security A Multifaceted Continuing Medical Education Intervention to Improve Primary Care Physicians’ Performance In Mexico.
REDUCING ANTIBIOTIC OVERUSE for ARIs with SMALL- GROUP EDUCATIONAL INTERVENTION Munawaroh S 1, Sunartono H 2, Suryawati S 3 1 INRUD Yogya/Indonesia; 2.
Does Drug Use Evaluation Required by National Policy Improve Use of Medicines? Akaleephan C*, Muenpa R**, Sittitanyakit B***, Treesak C #, Cheawchanwattana.
An unpleasant sensory or emotional experience associated with actual or potential tissue damage The World Health Organization (WHO) has stated that pain.
Pain Management VS Drug Addiction An Ethical Decision to Treat or Not BY Talisa Burris.
Comparison of Opioid Prescribing Guidelines Violations by Clinical Speciality Chia-Chen Teng1,2, Christy Porusnik3, Erin Johnson4, Robert Rolfs3, Jonathan.
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
Proctor’s Implementation Outcomes
The SPRINT Research Group
PECULLIARITIES OF CHRONIC PAIN ASSESSMENT AND MANAGEMENT
Optimizing Meds – Need for Systems Approach
Patient Safety Dimension in Primary Health Care Padang City
Evaluating Sepsis Guidelines and Patient Outcomes
Does Medical Student Knowledge on Intimate Partner Violence Change in Response to a Workshop Karen Richardson-Nassif, PhD, Martha Seagrave, PA-C, Julie.
Development of Inter-Professional Geriatric and Palliative Care Clinic
International Conference on Improving Use of Medicines
Polypharmacy In Adults: Small Test of Change
Impact of a public education program on promoting rational use of medicines:
Modeling Medical Records of Diabetes using Markov Decision Processes
Presented by Jim Grant, MA Physician Practice Pharmacy QIOSC FMQAI
Opioids in Butte County
Basics of Clinical Medicine Lecture Series:
Adherence, attitude to Standard Treatment Guidelines in clinical practice at tertiary care hospitals in Delhi State 1Sangeeta Sharma, 2Sharma KK, 3Sethi.
PH Dung, NTK Chuc and Dennis Ross Degan
A Multifaceted Continuing Medical Education Intervention to Improve Primary Care Physicians’ Performance In Mexico Hortensia Reyes, Ricardo Perez-Cuevas,
Toktobaeva B, Karymbaeva S Drug Information Centre Kyrgyzstan
The Research Question Does changing prescription medication labels to conform to the United States Pharmacopeia (USP) patient-centered, more understandable,
Introduction to Clinical Pharmacology Chapter 48 Urinary Tract Anti-Infectives and Other Urinary Drugs.
Alcohol, Other Drugs, and Health: Current Evidence July-August, 2018
Presentation transcript:

Svetlana V. Doubova Dolores Mino-Leon Hortensia Reyes Morales Sergio Flores-Hernández Ricardo Pérez-Cuevas

 There is a high frequency of prescription of non- opioid analgesics (NOAs), second only to cardiovascular drugs.  Several studies have reported that medical doctors do not prescribe properly and patients do not use the NOAs appropriately.  This finding is evidenced by overutilization rates of up to 41% and by the frequent appearance of preventable adverse events. -42% of the medical doctors are unaware of the adverse events that NOAs cause. -34% of patients are unsure about the proper method of taking NOAs, despite the fact that these are among the most common self-medicated drugs.

 To develop and test two educational programs (interactive and passive) aimed at improving family doctors’ (FDs) prescribing practices and patient’s knowledge and use of NOAs. Methods:  The educational programs were conducted in two family medicine clinics belonging to the Mexican Institute of Social Security in Mexico City. The study was performed in three stages: 1) Baseline evaluation 2) Implementation of educational activities 3) Post-program evaluation.

EDUCATIONAL PROGRAMS INTERACTIVE (IEP) PASSIVE (PEP) FAMILY DOCTORS WORKSHOPS, DISCUSSION GROUPS, IN-SERVICE TRAINING 1 MOUNTH PATIENTS VIDEO, LIFLET, INTERACTIVE EDUCATIONAL SESSION 1 OCASION PER PATIENTE FAMILY DOCTORS CLINICAL GUIDELINE 1 OCASION PATIENTS LIFLET 1 OCASION

All FDs working at the clinics were invited to participate in the programs, and most (99%) of them accepted the invitation.  There were 58 FDs in the IEP group and 52 FDs in the PEP group. The eligibility criteria for patients were:  age ≥ 50 years, suffered from non-malignant pain syndrome, had received at least one NOA prescription for a period of ≥ 7 days, were under the care of the participating FDs, and were able to answer the questions posed during the interview.  The baseline and post-program evaluations included 300 patients by group.

The effect of the programs:  on the FDs was measured through the appropriateness of prescriptions of NOA and analyzed using the differences-in-differences estimator (D-in-D)  on patients through changes in self-medication and in their knowledge about the proper use and adverse events by analyzing the inter- and intra- group differences before and after the programs.

Baseline evaluation stagePost-programs evaluation stage IEP n=58 Average proportion PEP n=52 Average proportion IEP n=58 Average proportion PEP n=52 Average proportion Paracetamol *42.9 NSAIDs*** NSAIDs contraindicated in the elderly *24.0 Simultaneous prescription of multiple NSAIDs NSAID prescribed to patients with chronic renal failure1.3* Prescription of NSAID without gastric protectors to patients in risk of gastrointestinal adverse effects 3.8* *p<0.05 between groups A comparison of data from the IEP and PEP groups (i.e., baseline and post- program evaluation data) revealed that prescription of paracetamol increased and NSAIDs decreased in the IEP group (p < 0.05), particularly with regard to prescriptions for elderly patients.

IEP n= 58 PEP n=52 Pre-intervention stage Average proportion 95% confidence interval 65.2 (59.5 – 71.0) 62.0 (56.1 – 67.9) Post-intervention stage Average proportion 95% confidence interval 82.6 ( 78.0 – 87.2) 68.0 (62.8 – 73.2) Difference in the average proportion 95% confidence interval 17.4 ** (11.0 – 23.7) 6.0 (-2.3 – 14.3) Differences-in-differences estimate* 95% confidence interval 15.0 † ( ) *The model was adjusted according to baseline evaluation data and seniority of the family doctors. **p < between pre- and post-intervention stages, within groups. **p < between pre- and post-intervention stages, within groups. † p < between IEP and PEP. In the IEP group, the mean difference in the proportion of appropriately prescribed NOAs between the baseline and post- intervention stages was 17.8% (p 0.05).

Table 3. Effect of educational programs on patients’ use of non-opioid analgesics. IEP n= 622 PEP n=607 Self-medication* Absolute percent difference 95% confidence interval -9.1 ( ) (– ) Knowledge about the proper way in which NOAs should be taken Absolute percent difference 95% confidence interval 8.5 (6.3 – 10.7) 8.5 (6.3 – 10.7) Knowledge about NOA adverse events* Absolute percent difference 95% confidence interval 39.6 (37.6 – 41.6) 9.2 ( ) *Abbreviation: NOA, non-opioid analgesics. * p < The percent differences in IEP and PEP patients reporting self-medication were –9.1% and –13.4%, respectively. The percent difference in knowledge of proper NOA administration was 8.5% in both groups, while awareness of adverse events was 39.6% in the IEP group and 9.2% in the PEP group

 The IEP aimed at patients and family doctors are superior to PEP in improving family doctors’ prescribing patterns and enhancing patients’ knowledge of NOA-associated adverse events.  Our findings suggest that programs aimed at improving medication use should focus on interactive educational activities.  The IEP had a positive effect on patients’ awareness of NOA-associated adverse events even though the intervention did not improve the ability of patients to identify gastrointestinal adverse events.  The IEP should be improved in this aspect, and novel programs should be developed to specifically educate patients about NOAs gastrointestinal adverse events.